Real World Evidence of Anifrolumab in Systemic Lupus Erythematosus: Investigator Initiated, Observational, Multicenter Study Evaluating Effectiveness and Safety of Anifrolumab in Active SLE Patients
Clinical trial NCT07215754 · RECRUITING
Trial details
- NCT number
- NCT07215754
- Sponsor
- University of Pisa
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2023-05-25
- Primary completion
- 2026-05-01
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.